USPTO serial 99006194
MOVEMENTUM
Reviewed by CopyMark Law Group
Status 731Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- GREEN, ASHLEY ELIZABETH
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with MOVEMENTUM?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $349*
Plus Government fees of $150
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Rebecca Dalton
Rebecca Dalton Covington & Burling LLPOne CityCenter, 850 Tenth Street NWWashington, DC 20001United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Foods adapted for medical use and specially formulated to meet the dietary needs of patients and used under a physician's supervision; Pharmaceutical preparations for the treatment, prevention, and management of pain product and opioid use disorders and reducing and managing the dosing and usage of pain products and narcotics; Vitamin preparations; Pharmaceutical preparations for restoring and maintaining health and function in the presence of pain, physical discomfort, stiffness, sensitization, energy, arterial, venous, circulatory, cognitive, mental, central nervous system, autoimmune and mobility limitations; Pharmaceutical preparations for the treatment and management of pain, physical discomfort, sensitization, energy, arterial, venous, circulatory, stiffness, and mobility limitations; Nutritional Supplements; Pharmaceutical preparations for the treatment, management, and maintenance of physical function in neurological, musculoskeletal, cardiovascular, fibromyalgia, cognitive, central nervous system, mental, fatigue, autoimmune, inflammatory, and oxidative conditions, ailments and disorders; Dietary supplements; Pharmaceutical preparations for the treatment, prevention, and management of neurological, musculoskeletal, fibromyalgia, cardiovascular, cognitive, central nervous system, mental, fatigue, autoimmune, inflammatory, and oxidative conditions, ailments and disorders; Foods adapted for medical use and specially formulated to meet the dietary needs of patients and used under a physician's supervision as adjunctive therapies to drugs, biologics, medical devices, physical and occupational therapy, and other treatment modalities to improve neurological, musculoskeletal, cardiovascular, fibromyalgia, cognitive, central nervous system, mental, autoimmune, inflammatory, and oxidative conditions and ailments; Foods adapted for medical use and specially formulated to meet the dietary needs of patients and used under a physician's supervision in the treatment, prevention, and management of pain product and opioid use disorders and reducing and managing the dosing and usage of pain products and narcotics; Pharmaceutical preparations as adjunctive therapies to drugs, biologics, medical devices, physical and occupational therapy, and other treatment modalities to improve neurological, musculoskeletal, cardiovascular, fibromyalgia, cognitive, central nervous system, mental, autoimmune, inflammatory, and oxidative conditions and ailments | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 21, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Oct 20, 2026 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Oct 20, 2026 | EXT2 | SOU EXTENSION 2 FILED | — |
| Oct 20, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 10, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 9, 2026 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Apr 9, 2026 | EXT1 | SOU EXTENSION 1 FILED | — |
| Apr 9, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 9, 2025 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Oct 14, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 14, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 8, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 16, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 16, 2025 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 16, 2025 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 16, 2025 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 16, 2025 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 2, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 2, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 2, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 26, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 17, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 17, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 17, 2025 | NWAP | NEW APPLICATION ENTERED | — |